Experts highlight AI adoption, sustained-release glaucoma therapies, and concerns about Medicare payment and rural access.
Grayson W. Armstrong, MD, MPH
Advertisement
Grayson W. Armstrong, MD, MPH, director, Massachusetts Eye and Ear.
Articles by Grayson W. Armstrong, MD, MPH
Cost, staffing, unbiased training data, and strong referral partnerships will decide whether AI eye screening reaches patients at highest risk of vision loss.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
Kidney Week 2026 Recap: IgAN Advances, Value-Based Care, CKD Care Gaps
3
Elagolix Noninferior to Dienogest for Endometriosis Pain in Phase 3 Trial
4
Disability, Economic Toll of Multimorbidity Climb in Older Adults
5